![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 28, 2002
Department of Medical Microbiology, Royal Free & University College Medical School, London NW3 2PF
Corresponding Author: b.charalambous{at}rfc.ucl.ac.uk
Phage displaying random cyclic 7-mer, and linear 7-mer and 12-mer peptides at the N-terminus of the coat protein, pIII were panned with the murine monoclonal antibody, 9-2-L379 specific for meningococcal lipooligosaccharide. Five cyclic peptides with two sequence motifs, six linear 7-mers and five linear 12-mers with different sequence motifs were identified. Only phage displaying cyclic peptides were specifically captured by and were antigenic for 9-2-L379. Monoclonal antibody 9-2-L379 exhibited ¡§apparent¡¨ binding affinities to the cyclic peptides between 11 ¡V 184nM, comparable to lipooligosaccharide. All cyclic peptides competed with the binding of 9-2-L379 to lipooligosaccharide with EC50 values in the range 10 ¡V 105ÝM, which correlated with their ¡§apparent¡¨ binding affinities. Structural modifications of the cyclic peptides eliminated their ability to bind and compete with mAb 9-2-L379. Mice (C3H/HeN) immunised with the cyclic peptide with optimal ¡§apparent¡¨ binding affinity and EC50 of competition elicited cross-reactive antibodies to meningococcal lipooligosaccharide with end-point dilution serum antibody titres of 3200. Cyclic peptides were converted to T-cell dependent immunogens without disrupting these properties by C-terminal biotinylation and complexing with NeutrAvidin¥. The data indicate that constrained peptides can cross-react with a carbohydrate-specific antibody with greater specificity than linear peptides, and critical to this specificity is their structural conformation.
J. Biol. Chem, 10.1074/jbc.M200387200
Submitted on January 14, 2002
Revised on March 28, 2002
Accepted on March 28, 2002
Characterisation of oligopeptides that cross-react with carbohydrate specific antibodies by real-time kinetic, in-solution competition ELISA and immunological analyses
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Menendez, D. A. Calarese, R. L. Stanfield, K. C. Chow, C. N. Scanlan, R. Kunert, H. Katinger, D. R. Burton, I. A. Wilson, and J. K. Scott A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120 FASEB J, May 1, 2008; 22(5): 1380 - 1392. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |